William W Bachovchin

USPTO Granted Patents = 62 (Patent Applications = 32)

CIPO Patents = 2 (Patent Applications = 10)

EPO Patents = 8 (Patent Applications = 25)

Average Co-Inventor Count = 2.2

ph-index = 13

Forward Citations = 680(Granted Patents)

Forward Citations (Not Self Cited) = 512(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Melrose, MA (US) (1990 - 2013)
Cambridge, MA (US) (2009 - 2024)

Company Filing History:

Bach Biosciences, LLC

patents

8 out of 97

New England Medical Center Hospitals. Inc.

patents

4. 6 out of 24

1149336 Ontario, Inc.

Arisaph Pharmaceuticals, Inc.

patents

7. 1 out of 16,338

E.i. Dupont De Nemours and Company

patents

8. 1 out of 1,371

The Brigham and Women's Hospital, Inc.

patents

where one patent can have more than one assignee

Years Active: 1990-2025

Loading Chart...

Areas of Expertise:

Immuno-DASH Inhibitors

PGE2 Antagonists

FAP-Activated Therapeutic Agents

Proteasome Inhibitors

Dendritic Cell Cancer Vaccines

Caspase-1 Dependent Anticancer Agents

Fibroblast Activation Protein Alpha

Niacin Mimetics

Soft Protease Inhibitors

GLP-1 Analogs

Peptidomimetic Inhibitors

Smart Pro-Drugs

62 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12478609 - Combination therapies using immuno-DASH inhibitors and PGE2 antagonists (2025-11-25),

2. 12214047 - FAP-activated proteasome inhibitors for treating solid tumors (2025-02-04),

3. 12121505 - Fap-activated therapeutic agents, and uses related thereto (2024-10-22),

4. 12053450 - FAP-activated therapeutic agents, and uses related thereto (2024-08-06),

5. 12023316 - FAP-activated therapeutic agents, and uses related thereto (2024-07-02),

6. 11957657 - Combination therapies using immuno-dash inhibitors and PGE2 antagonists (2024-04-16),

7. 11925655 - FAP-activated therapeutic agents, and uses related thereto (2024-03-12),

8. 11707539 - FAP-targeted radiopharmaceuticals and imaging agents, and uses related thereto (2023-07-25),

9. 11583516 - Dash inhibitors, and uses related thereto (2023-02-21),

10. 11559537 - Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists (2023-01-24),

11. 11266669 - FAP-activated therapeutic agents, and uses related thereto (2022-03-08),

12. 11096924 - Combination therapies using immuno-dash inhibitors and PGE2 antagonists (2021-08-24),

13. 11065339 - FAP-activated proteasome inhibitors for treating solid tumors (2021-07-20),

14. 11033525 - Fap-activated therapeutic agents, and uses related thereto (2021-06-15),

15. 10709722 - FAP-activated therapeutic agents, and uses related thereto (2020-07-14),

Title: The Innovative Journey of William W Bachovchin

Introduction: William W Bachovchin is a renowned inventor based in Cambridge, MA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: William W Bachovchin holds several patents in the areas of biotechnology, pharmaceuticals, and materials science, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, William W Bachovchin has worked with leading research institutions and companies, consistently pushing the boundaries of scientific discovery and technological advancement.

Collaborations: Throughout his career, William W Bachovchin has collaborated with top universities, research institutions, and industry experts, fostering a culture of innovation and knowledge sharing.

Conclusion: William W Bachovchin's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.